Tower Research Capital (TRC)’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-738
| Closed | -$2.8K | – | 5320 |
|
|
2025
Q1 | $2.8K | Buy |
+738
| New | +$2.8K | ﹤0.01% | 4506 |
|
|
2024
Q4 | – | Sell |
-1,118
| Closed | -$4.68K | – | 5749 |
|
|
2024
Q3 | $4.68K | Sell |
1,118
-770
| -41% | -$3.23K | ﹤0.01% | 4451 |
|
|
2024
Q2 | $5.57K | Sell |
1,888
-808
| -30% | -$2.38K | ﹤0.01% | 4671 |
|
|
2024
Q1 | $7.47K | Sell |
2,696
-4,568
| -63% | -$12.7K | ﹤0.01% | 4197 |
|
|
2023
Q4 | $20.6K | Buy |
7,264
+3,503
| +93% | +$9.95K | ﹤0.01% | 3627 |
|
|
2023
Q3 | $9.7K | Sell |
3,761
-2,479
| -40% | -$6.4K | ﹤0.01% | 4189 |
|
|
2023
Q2 | $27K | Buy |
6,240
+254
| +4% | +$1.1K | ﹤0.01% | 3100 |
|
|
2023
Q1 | $9K | Buy |
5,986
+2,302
| +62% | +$3.46K | ﹤0.01% | 4477 |
|
|
2022
Q4 | $6K | Buy |
3,684
+2,706
| +277% | +$4.41K | ﹤0.01% | 4704 |
|
|
2022
Q3 | $1K | Sell |
978
-1,792
| -65% | -$1.83K | ﹤0.01% | 5752 |
|
|
2022
Q2 | $6K | Buy |
2,770
+1,102
| +66% | +$2.39K | ﹤0.01% | 4910 |
|
|
2022
Q1 | $5K | Sell |
1,668
-7,692
| -82% | -$23.1K | ﹤0.01% | 5038 |
|
|
2021
Q4 | $35K | Buy |
9,360
+7,890
| +537% | +$29.5K | ﹤0.01% | 3078 |
|
|
2021
Q3 | $6K | Sell |
1,470
-3,479
| -70% | -$14.2K | ﹤0.01% | 4740 |
|
|
2021
Q2 | $22K | Buy |
4,949
+4,039
| +444% | +$18K | ﹤0.01% | 3794 |
|
|
2021
Q1 | $8K | Buy |
+910
| New | +$8K | ﹤0.01% | 4461 |
|
|
2020
Q4 | – | Sell |
-1,383
| Closed | -$6K | – | 5166 |
|
|
2020
Q3 | $6K | Buy |
+1,383
| New | +$6K | ﹤0.01% | 4283 |
|
|
2019
Q2 | – | Sell |
-71
| Closed | – | – | 3808 |
|
|
2019
Q1 | $0 | Buy |
+71
| New | – | ﹤0.01% | 3876 |
|